Kattermann, Krystina E.
Massachusetts General Hospital
2 papers on CoChat
Most cited papers
- Verified
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer
Yoda, S., Lin, J. J., Lawrence, M. S., Burke, B. J., Friboulet, L., Langenbucher, A., Dardaei, L., Prutisto-Chang, K., Dagogo-Jack, I., Timofeevski, S., et al. (2018) · Cancer Discovery
Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics
Cited by 322
- Verified
Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
Raoof, S., Mulford, I. J., Frisco-Cabanos, H., Nangia, V., Timonina, D., Labrot, E., Hafeez, N., Bilton, S. J., Drier, Y., Ji, F., et al. (2019) · Oncogene
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 216
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free